Recent Updates
Recently added Catalysts
TENX

I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed. Chris Stern

Key Takeaway: I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~24 mo
Minimal dilution risk
Lead asset
Levosimendan
Phase 3 · Coronary Artery Bypass Grafting

Full Press Release Details

I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed.
Last updated: Aug 26, 2011